Share Price:

APNASPENAspen Pharmacare Hldgs10138130 (1.30%)

Update on the reported key anti-retroviral (ARV) Tenofovir (TDF) public sector supply shortages

Johannesburg โ€“ over the past days and weeks, there have been widespread reports from various State Clinics, in certain provinces, that patients have been unable to access supplies of TDF, a key ARV, used primarily in first line HIV treatment. Due to the negative consequences on both patients and the sustainability of South Africaโ€™s Public… Continue reading Update on the reported key anti-retroviral (ARV) Tenofovir (TDF) public sector supply shortages

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.